|
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis
|
5R01CA185251-04
|
$700,207
|
BEEBE, DAVID
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Yale SPORE in Skin Cancer
|
2P50CA121974-11A1
|
$2,500,000
|
BOSENBERG, MARCUS
|
YALE UNIVERSITY
|
|
Yale SPORE in Skin Cancer
|
3P50CA121974-10S1
|
$25,000
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
Yale SPORE in Skin Cancer
|
3P50CA121974-10S2
|
$709,079
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
|
5P50CA196530-03
|
$2,300,000
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
|
5P50CA196530-04
|
$2,507,598
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S1
|
$117,999
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S2
|
$60,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S3
|
$125,625
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S4
|
$200,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S5
|
$250,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-38
|
$2,600,006
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
WNT4 IN ENDOCRINE RESPONSE AND RESISTANCE IN INVASIVE LOBULAR CARCINOMA
|
4R00CA193734-03
|
$249,000
|
SIKORA, MATTHEW
|
UNIVERSITY OF COLORADO DENVER
|
|
Wnt/?-catenin Signaling in Pancreatic Oncogenesis
|
1R01CA220236-01
|
$366,000
|
XIE, KEPING
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Wiskott-Aldrich syndrome protein (WASp) signaling in the oncogenesis of T cell lymphomas
|
1K08CA218460-01
|
$106,531
|
MURGA-ZAMALLOA, CARLOS
|
UNIVERSITY OF MICHIGAN
|
|
Wiskott-Aldrich syndrome protein (WASp) signaling in the oncogenesis of T cell lymphomas
|
5K08CA218460-02
|
$106,531
|
MURGA-ZAMALLOA, CARLOS
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-09
|
$2,524,399
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S1
|
$59,999
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S2
|
$102,081
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S1
|
$72,918
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S2
|
$200,473
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S3
|
$234,000
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-10
|
$2,574,000
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
|
1P50CA211024-01A1
|
$2,184,999
|
RUBIN, MARK
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Water Soluble Polymers to Target Tumor-Associated Extracellular Matrix for Delivery of MMP Inhibitors
|
1F31CA213901-01A1
|
$44,044
|
SUBRAHMANYAM, NITHYA
|
UNIVERSITY OF UTAH
|
|
Washington University SPORE in Pancreatic Cancer
|
5P50CA196510-02
|
$2,143,077
|
HAWKINS, WILLIAM
|
WASHINGTON UNIVERSITY
|
|
Washington University SPORE in Pancreatic Cancer
|
5P50CA196510-03
|
$2,300,000
|
HAWKINS, WILLIAM
|
WASHINGTON UNIVERSITY
|
|
Washington University Human Tumor Atlas Research Center
|
1U2CCA233303-01
|
$1,752,191
|
DING, LI
|
WASHINGTON UNIVERSITY
|
|
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
|
5R01CA194404-03
|
$332,363
|
BARBER, GLEN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Vermont PROSPR Research Center (VPRC)
|
3U54CA163303-05S3
|
$608,939
|
SPRAGUE, BRIAN
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
Vermont Breast Cancer Molecular Characterization Laboratory
|
3U01CA196383-03S1
|
$312,000
|
STEIN, JANET
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
VEGF signaling in Mammary Tumorigenesis
|
2R01CA168464-06
|
$397,813
|
MERCURIO, ARTHUR
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
VCU Massey Cancer Center Support Grant
|
2P30CA016059-36
|
$2,164,167
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-36S1
|
$124,341
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-36S2
|
$19,990
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S1
|
$218,356
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S2
|
$203,848
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S3
|
$86,197
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
5P30CA016059-37
|
$2,170,000
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Vascular Biology Section
|
ZIA BC 011390
|
$1,151,796
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
Vangl Dependent PCP Signaling Mediates EMT Induced Cell Invasiveness
|
5F31CA210467-02
|
$38,596
|
VANDERVORST, KACEY
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Validation of circulating tumor DNA assays for detection of metastatic melanoma
|
5UH2CA206124-02
|
$248,101
|
POLSKY, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
3U01CA200466-02S1
|
$129,694
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
5U01CA200466-02
|
$1,537,769
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
5U01CA200466-03
|
$1,563,388
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Validation of a novel, adjuvant implant for post-metastatic skeletal lesions
|
1R43CA221553-01A1
|
$299,958
|
MARGULIES, BRYAN
|
FUSOLOGICS, LLC
|
|
Validating and Characterizing a New Melanoma Therapeutic Target
|
1R01CA217625-01
|
$646,803
|
COURTNEIDGE, SARA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S1
|
$125,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S2
|
$31,772
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|